Revefenacin in Chinese Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease(COPD)

Condition:   COPD Interventions:   Drug: Revefenacin 175 mcg in 3 ML Inhalation Solution;   Drug: Placebo inhalation solution QD Sponsors:   Mylan Inc.;   Mylan Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials